Respiratory syncytial (RS) virus is the main cause of severe respiratory infections in newborns and infants during the first year of life. In the recent years, search is under way for chemo- and immune replacement therapy preparations for etiotropic RS-infection therapy. Procedures have been developed to prepare immunoglobulins and Chigain preparations having a target-oriented action. They were clinically tested. There was a positive dynamics in the clinical manifestations of the disease and a positive influence on immunological parameters in children.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
replacement therapy
8
[immune replacement
4
therapy infection]
4
infection] respiratory
4
respiratory syncytial
4
syncytial virus
4
virus main
4
main severe
4
severe respiratory
4
respiratory infections
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!